SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
IGEN International
An SI Board Since January 1997
Posts SubjectMarks Bans Symbol
1025 31 0 IGEN
Emcee:  John Zwiener Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
825No Perfect Partnership; Igen Learns Lesson of Small-Firm Risks, Big Marketing Pa613-6/3/2002
824Some Roche press... Fresh Start 2002: Roche's New Scientific Method Messasim1-5/26/2002
823Another option expiry close around 40? What a surprise! I'll bet the SEC i613-5/16/2002
822>>GAITHERSBURG, Md., May 16 /PRNewswire-FirstCall/ -- IGEN International, tuck-5/16/2002
821One significant nugget from the CC - IGEN implied that some language in their liBiomaven-5/15/2002
820IGEN Reports Fiscal Year 2002 Results - Revenue Increased to Record Levels for B613-5/15/2002
819Earnings tonight. If nothing announced to further value, MM's will be able 613-5/15/2002
818Looks like MM's are preparing for the 40+/- option expiry close - again! No 613-5/13/2002
817IGEN International, Inc.: Company takes steps to maximize diagnostic market oppo613-5/10/2002
816Roche to Sell Off Vitamin Division Bloomberg News April 25 2002 Roche Holdingsim1-4/25/2002
815As I understand it, it's essentially status quo in terms of what Roche can dBiomaven-4/19/2002
814RCMac is better qualified than just about anybody else to answer you specificalltom pope-4/19/2002
813Can anyone clarify - posts on Yahoo board seem to indicate that IGEN can effecti613-4/19/2002
812Roche plays down impact of IGEN licensing row. ZURICH, April 17 (Reuters) - Ro613-4/17/2002
811And link to the Roche spin: quote.bloomberg.com Same old, same old from both stuck-4/15/2002
810>>GAITHERSBURG, Md., April 15 /PRNewswire-FirstCall/ -- IGEN Internationaltuck-4/15/2002
809So I was digging around the literature looking for measures of specificity and stuck-4/5/2002
808opinions re. IGEN's ability to use ECL freely? biofind.com from the site ltom r. phillips-3/28/2002
807Close within pennies of the option price. What a surprise - not. The only good 613-3/18/2002
806"Roche rumbled and facing bid" independent.co.uk <i>Swiss drugs nigel bates-3/17/2002
805<i>One line of speculation is that Novartis might buy or ally with IGEN toBiomaven-3/16/2002
804<i>Novartis paid $2.8bn for a fifth of Roche's voting shares last yearRCMac-3/14/2002
803Novartis may be preparing bid for Roche By David Firn in London [FT] Published: sim1-3/14/2002
802Igen Lands Defense Contract Md. Biotech Firm to Supply Army With Tests for Toxisim1-3/14/2002
801Ft. Detrick is, of course, one of the military labs at which experiments with anquidditch-3/13/2002
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News